AQST:NASDAQ, Aquestive Therapeutics, Inc.
AQST stock overview
Aquestive Therapeutics, Inc. (AQST:NASDAQ) closed at $3.91 on November 13, 2026,
up 9.52% on the day.
The stock trades 41.9% below its 52-week high of $6.74
and 33.4% above its 52-week low of $2.93.
Over the past year, it lost 27.5%.
Aquestive Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $3.91
- Day change
- +9.52%
- Volume
- 3,962,398
- Average volume
- 2,590,462
- Market cap
- 491M+
- 52-week range
- $2.93 – $6.74
- 50-day average
- $4.40
- 200-day average
- $4.22
Price action over the past year
In 252 trading sessions since November 13, 2025, AQST closed higher on 115 days (46%).
Its best day was February 2, 2026 (+38.98%) and its worst was January 9, 2026 (-37.04%).
The stock moved 10% or more in a single session 7 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
AQST news
-
Nov 9, 2026:
Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference
-
Nov 6, 2026:
Aquestive Therapeutics Inc (AQST) (Q3 2026) Earnings Call Highlights: Revenue Dip Masks Anifilm ...
-
Nov 5, 2026:
Aquestive Therapeutics to Present Data at the 2026 ACAAI Annual Meeting
-
Nov 4, 2026:
Aquestive Therapeutics, Inc. Q3 2026 Earnings Call Summary
-
Nov 4, 2026:
Aquestive (AQST) Q3 2026 Earnings Call Transcript
-
Nov 4, 2026:
What Aquestive Therapeutics (AQST) Said on Its Q3 Earnings Call
-
Nov 4, 2026:
Aquestive Misses As Suboxone Order Timing Hits Q3 Revenue, But The Quarter Matters Less Than The March 2027 Anaphylm Decision
-
Nov 3, 2026:
Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company that advances and commercializes medicines to solve critical health care problems.
Similar stocks
Find more stocks like AQST with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.